120 related articles for article (PubMed ID: 2039826)
21. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
[TBL] [Abstract][Full Text] [Related]
22. Effects of IL-7 on human lymphocytes.
Kim HS; Kang CM; Findley H; Ragab AH
J Korean Med Sci; 1993 Apr; 8(2):93-8. PubMed ID: 8397935
[TBL] [Abstract][Full Text] [Related]
23. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors.
Wolf ML; Buckley JA; Goldfarb A; Law CL; LeBien TW
J Immunol; 1991 Nov; 147(10):3324-30. PubMed ID: 1719075
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Karawajew L; Ruppert V; Wuchter C; Kösser A; Schrappe M; Dörken B; Ludwig WD
Blood; 2000 Jul; 96(1):297-306. PubMed ID: 10891465
[TBL] [Abstract][Full Text] [Related]
25. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
[TBL] [Abstract][Full Text] [Related]
26. Structure/function analyses of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias.
Wörmann B; Anderson JM; Ling ZD; LeBien TW
Leukemia; 1987 Sep; 1(9):660-6. PubMed ID: 3118114
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
28. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.
Bertrand FE; Vogtenhuber C; Shah N; LeBien TW
Blood; 2001 Dec; 98(12):3398-405. PubMed ID: 11719380
[TBL] [Abstract][Full Text] [Related]
29. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.
Andreeff M; Tafuri A; Hegewisch-Becker S
Haematol Blood Transfus; 1990; 33():747-62. PubMed ID: 2323674
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro.
Dittel BN; LeBien TW
Blood; 1995 Oct; 86(7):2833-41. PubMed ID: 7545475
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.
Wuchter C; Ruppert V; Schrappe M; Dörken B; Ludwig WD; Karawajew L
Blood; 2002 Jun; 99(11):4109-15. PubMed ID: 12010814
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-4 inhibits proliferation of human leukemic megakaryoblast cell line MHH 225.
Hassan HT; Grell S; Borrmann-Danso U; Freund M
Hematol Oncol; 1994; 12(2):61-6. PubMed ID: 7520882
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotypic analysis of clonogenic cells in acute lymphoblastic leukemia using an in vitro colony assay.
Hudson AM; Makrynikola V; Kabral A; Bradstock KF
Blood; 1989 Nov; 74(6):2112-20. PubMed ID: 2804349
[TBL] [Abstract][Full Text] [Related]
34. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus.
Larson AW; LeBien TW
J Immunol; 1994 Jul; 153(2):584-94. PubMed ID: 7517420
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22.
Ohyashiki K; Miyauchi J; Ohyashiki JH; Saito M; Yaguchi M; Inatomi Y; Nakazawa S; Waca H; Mizutani S; Matsuo Y
Leukemia; 1993 Jul; 7(7):1034-40. PubMed ID: 7686604
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of childhood acute lymphoblastic leukemia (ALL): monoclonal antibodies phenotyping and induction of differentiation in vitro.
Umiel T; Luria D; Stark B; Cohen IJ; Gozes Y; Kobiler D; Kodman Y; Grunspan A; Dvir A; Yaniv I
Leukemia; 1988 Dec; 2(12 Suppl):88S-96S. PubMed ID: 3264367
[TBL] [Abstract][Full Text] [Related]
37. Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.
Barata JT; Keenan TD; Silva A; Nadler LM; Boussiotis VA; Cardoso AA
Haematologica; 2004 Dec; 89(12):1459-67. PubMed ID: 15590396
[TBL] [Abstract][Full Text] [Related]
38. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors.
Renard N; Duvert V; Banchereau J; Saeland S
Blood; 1994 Oct; 84(7):2253-60. PubMed ID: 7919343
[TBL] [Abstract][Full Text] [Related]
40. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection.
Weir EG; Cowan K; LeBeau P; Borowitz MJ
Leukemia; 1999 Apr; 13(4):558-67. PubMed ID: 10214862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
